Sanofi India Ltd (SANOFI) — Insider Trading | 28 September 2026 (3 announcements)

Sanofi India disclosed an insider transaction where promoter Hoechst GmbH transferred shares to Sanofi Healthcare India Private Limited via a block deal on September 25, 2026, as required under SEBI PIT Regulation 7(2)(b).

Sanofi India disclosed an insider trading transaction where Sanofi Healthcare India Private Limited, a promoter entity, purchased 3.5 million shares via block deal on September 25, 2026, representing 15.20% of total equity. The transaction was executed on BSE as an inter-se transfer among promoter group members. This disclosure complies with SEBI PIT Regulations Regulation 7(2)(b) requirements for material changes in promoter holdings.

Sanofi Healthcare India Private Limited acquired 3,500,000 shares representing 15.20% of Sanofi India Ltd from promoter Hoechst GmbH via block deal on 24 September 2026, as an inter-se transfer among promoters exempt under SEBI SAST Regulation 10(1)(a)(iii). The transaction followed mandatory Regulation 10(5) disclosure filed on 17 September 2026, with post-acquisition promoter holding unchanged at 45.18% for Hoechst GmbH and 0.02% for Sanofi Healthcare India Private Limited.